74 related articles for article (PubMed ID: 3621199)
1. Novel intrapulmonary model for orthotopic propagation of human lung cancers in athymic nude mice.
McLemore TL; Liu MC; Blacker PC; Gregg M; Alley MC; Abbott BJ; Shoemaker RH; Bohlman ME; Litterst CC; Hubbard WC
Cancer Res; 1987 Oct; 47(19):5132-40. PubMed ID: 3621199
[TBL] [Abstract][Full Text] [Related]
2. On Target: An Intrapulmonary Transplantation Method for Modelling Lung Tumor Development in its Native Microenvironment.
McDonald JA; Scott L; Van Zuylekom J; Holloway S; Blyth BJ; Sutherland KD
Methods Mol Biol; 2023; 2691():31-41. PubMed ID: 37355535
[TBL] [Abstract][Full Text] [Related]
3. Does the mouse tail vein injection method provide a good model of lung cancer?
Shrestha N; Lateef Z; Martey O; Bland AR; Nimick M; Rosengren R; Ashton JC
F1000Res; 2019; 8():190. PubMed ID: 31448098
[TBL] [Abstract][Full Text] [Related]
4. Precise and Facile Endotracheal Lung-tumor-implantation Mouse Model Visualized by GFP Expression.
Aoki Y; Kobayashi KJ; Varshney N; Kubota Y; Masaki N; Obara K; Wang JD; Tome Y; Bouvet M; Nishida K; Hoffman RM
In Vivo; 2023; 37(4):1477-1481. PubMed ID: 37369517
[TBL] [Abstract][Full Text] [Related]
5. A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology.
Tanaka R; Yoshinouchi S; Karouji K; Tanaka Y; Tominari T; Hirata M; Matsumoto C; Itoh Y; Miyaura C; Inada M
FEBS Open Bio; 2023 Jan; 13(1):51-59. PubMed ID: 36102619
[TBL] [Abstract][Full Text] [Related]
6. Mapping lung squamous cell carcinoma pathogenesis through in vitro and in vivo models.
Gómez-López S; Whiteman ZE; Janes SM
Commun Biol; 2021 Aug; 4(1):937. PubMed ID: 34354223
[TBL] [Abstract][Full Text] [Related]
7. Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories.
Hynds RE; Frese KK; Pearce DR; Grönroos E; Dive C; Swanton C
Open Biol; 2021 Jan; 11(1):200247. PubMed ID: 33435818
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells.
Dorvignit D; Boligan KF; Relova-Hernández E; Clavell M; López A; Labrada M; Simon HU; López-Requena A; Mesa C; von Gunten S
Sci Rep; 2019 Jul; 9(1):9921. PubMed ID: 31289278
[TBL] [Abstract][Full Text] [Related]
9. Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.
Eapen MS; Hansbro PM; Larsson-Callerfelt AK; Jolly MK; Myers S; Sharma P; Jones B; Rahman MA; Markos J; Chia C; Larby J; Haug G; Hardikar A; Weber HC; Mabeza G; Cavalheri V; Khor YH; McDonald CF; Sohal SS
Drugs; 2018 Nov; 78(16):1717-1740. PubMed ID: 30392114
[TBL] [Abstract][Full Text] [Related]
10. A Novel Method for Quantifying Total Thoracic Tumor Burden in Mice.
Viswanath P; Peng S; Singh R; Kingsley C; Balter PA; Johnson FM
Neoplasia; 2018 Oct; 20(10):975-984. PubMed ID: 30157470
[TBL] [Abstract][Full Text] [Related]
11. Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.
Lwin TM; Hoffman RM; Bouvet M
J Surg Oncol; 2018 Aug; 118(2):253-264. PubMed ID: 30080930
[TBL] [Abstract][Full Text] [Related]
12. Real-time computed tomography fluoroscopy-guided solitary lung tumor model in a rabbit.
Choi BH; Young HS; Quan YH; Rho JY; Eo JS; Han KN; Choi YH; Kim HK
PLoS One; 2017; 12(6):e0179220. PubMed ID: 28609443
[TBL] [Abstract][Full Text] [Related]
13. Lung carcinoma progression and survival versus amino- and carboxyl-parathyroid hormone-related protein expression.
Hastings RH; Montgrain PR; Quintana RA; Chobrutskiy B; Davani A; Miyanohara A; Mahooti S
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1395-1407. PubMed ID: 28342003
[TBL] [Abstract][Full Text] [Related]
14. An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients.
Taromi S; Kayser G; von Elverfeldt D; Reichardt W; Braun F; Weber WA; Zeiser R; Burger M
Clin Exp Metastasis; 2016 Oct; 33(7):651-60. PubMed ID: 27380917
[TBL] [Abstract][Full Text] [Related]
15. Using Dual Fluorescence Reporting Genes to Establish an In Vivo Imaging Model of Orthotopic Lung Adenocarcinoma in Mice.
Lai CW; Chen HL; Yen CC; Wang JL; Yang SH; Chen CM
Mol Imaging Biol; 2016 Dec; 18(6):849-859. PubMed ID: 27197534
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Murine Models for Lung Cancer: Clinical Trial Applications.
Kellar A; Egan C; Morris D
Biomed Res Int; 2015; 2015():621324. PubMed ID: 26064932
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles.
Peng L; Feng L; Yuan H; Benhabbour SR; Mumper RJ
Nanomedicine; 2014 Oct; 10(7):1497-506. PubMed ID: 24709328
[TBL] [Abstract][Full Text] [Related]
18. Assessment of M867, a selective caspase-3 inhibitor, in an orthotopic mouse model for non-small cell lung carcinoma.
Li B; Blanc JM; Sun Y; Yang L; Zaorsky NG; Giacalone NJ; Torossian A; Lu B
Am J Cancer Res; 2014; 4(2):161-71. PubMed ID: 24660105
[TBL] [Abstract][Full Text] [Related]
19. Utility and applications of orthotopic models of human non-small cell lung cancer (NSCLC) for the evaluation of novel and emerging cancer therapeutics.
Justilien V; Fields AP
Curr Protoc Pharmacol; 2013 Oct; 62():14.27.1-14.27.17. PubMed ID: 24510718
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft models.
Coxon A; Ziegler B; Kaufman S; Xu M; Wang H; Weishuhn D; Schmidt J; Sweet H; Starnes C; Saffran D; Polverino A
Mol Cancer; 2012 Sep; 11():70. PubMed ID: 22992329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
